Construction and immunogenicity of recombinant adenovirus expressing the major outer membrane protein (MOMP) of Chlamydophila psittaci in chicks

Vaccine

Volumn 25, Issue 34, 2007, Pages 6367-6372

  Zhou, Jizhang ^a   Qiu, Changqing ^a   Cao, Xiao An ^a   Lin, Guozhen ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Chick; Chlamydophila psittaci; Immunogenicity; MOMP gene; Recombinant adenovirus

Indexed keywords

ADENOVIRUS VECTOR; BACTERIAL VACCINE; MAJOR OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL GENE; CHICKEN; CHLAMYDIASIS; CHLAMYDOPHILA PSITTACI; CONTROLLED STUDY; CYTOMEGALOVIRUS; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; GENETIC ENGINEERING; HEMAGGLUTINATION TEST; HUMAN; HUMAN CELL; IMMUNOGENICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECOMBINANT PLASMID; SHUTTLE VECTOR; TREATMENT OUTCOME; VACCINE PRODUCTION; VIRAL GENE DELIVERY SYSTEM; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; CHICKENS; CHLAMYDOPHILA PSITTACI; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINATION; VACCINES, SYNTHETIC;

EID: 34547111560     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.06.031     Document Type: Article

References (23)

1. Friis R.R. Interaction of L cells and C. psittaci: entry of the parasite and host responses to its development. J Bacteriol 110 (1972) 706-721
2. Andersen A.A. Two new serovars of C. psittaci from North American birds. J Vet Diag Invest 9 2 (1997) 159-164
3. Vanrompay D., Ducatelle R., and Haeserouck F. C. psittaci infection: a review with emphasis on avian chlamydiosis. Vet Microbiol 45 2-3 (1995) 93-119
4. Olsen B.J., and Treuting W.L. An epidemic of a severe pneumonitis in the Bayou region of Louisiana. Public Health Rep 59 (1944) 1299-1311
5. Broholm K.A., Böttiger M., Jernelius H., Johansson M., Grandien M., and Sölver K. Ornithosis as a nosocomial infection. Scand J Infect Dis 9 4 (1977) 263-267
6. Meyer K.F., and Eddie B. Human carrier of the psittacosis virus. J Infect Dis 88 (1951) 109-125
7. Pether JVS. Psittacosis infection from patient to staff. Communicable Disease Report (PHLS); May 1981.
8. Arzey K.E., Arzey G.G., and Reece R.L. Chlamydiosis in commercial ducks. Aust Vet J 67 9 (1990) 333-334
9. Caldwell H.D., Kromhout J., and Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 31 (1981) 1161-1176
10. Hatch T.P., Vance W., and Al-Hossainey. Identification of a major outer envelope protein in Chlamydia spp. J Bacteriol 146 (1981) 426-429
11. Westbay T.D., Dascher C.C., Hsia R.C., Bavoil P.M., and Zauderer M. Dissociation of immune determinants of outer membrane proteins of C. psittaci strain in guinea pig inclusion conjunctivitis. Infect Immun 62 (1994) 5614-5623
12. Vanrompay D., Cox E., Volckaert G., and Goddeeris B. Turkeys are protected from infection with Chlamydia psittaci by plasmid DNA vaccination against the major outer membrane protein. Clin Exp Immunol 118 (1999) 49-55
13. Vanrompay D., Cox E., Vandenbussche F., Volckaert G., and Goddeeris B. Protection of turkeys against C. psittaci challenge by gene gun-based DNA immunizations. Vaccine 17 20-21 (1999) 2628-2635
14. Vanrompay D., Cox E., Kaiser P., Lawson S., VanLoock M., Volckaert G., et al. Protection of turkeys against Chlamydophila psittaci challenge by parenteral and mucosal inoculations and the effect of turkey interferon-gamma on genetic immunization. Immunology 103 1 (2001) 106-112
15. Vanrompay D., Vanloock M., Cox E., Goddeeris B.M., and Volekaert G. Genetic immunization for Chlamydia psittaci. Verh K Acad Geneeskd Belg 149 11 (2001) 332-334
16. Verminnen K., Loock M.V., Cox E., Goddeeris B.M., and Vanrompay D. Protection of turkeys against Chlamydophila psittaci challenge by DNA and rMOMP vaccination and evaluation of the immunomodulating effect of 1 alpha, 25-dihydroxyvitamin D(3). Vaccine 23 36 (2005) 4509-4516
17. Loots K., Loock M.V., Vanrompay D., and Goddeeris B.M. CpG motifs as adjuvant in DNA vaccination against Chlamydophila psittaci in turkeys. Vaccine 24 21 (2006) 4598-4601
18. Randrianarison-Jewtoukoff V., and Perricaudet M. Recombinant adenoviruses as vaccines. Biologicals 23 2 (1995) 145-157
19. Adam E., and Nasz I. Significance of recombinant adenovirus in experimental gene therapy. Orv Hetil 136 15 (1995) 755-761
20. Grimes J.E., and Page L.A. Comparison of direct and modified direct complement-fixation and agar-gel precipitin methods in detecting chlamydial antibody in wild birds. Avian Dis 22 3 (1978) 422-430
21. Schmeer N., Krauss H., Apel J., Adami M., Muller H.P., Schneider W., et al. Analysis of caprine IgG1 and IgG2 subclass response to C. psittaci infection and vaccination. Vet Microbiol 14 2 (1987) 125-135
22. Batteiger B.E., and Rank R.G. Analysis of the humoral immune response to chlamydial genital infection in guinea pigs. Infect Immun 55 8 (1987) 1767-1773
23. Tan T.W., Herring A.J., Anderson I.E., and Jones G.E. Protection of sheep against Chalmydia psittaci infection with a subcellular vaccine containing the major outer membrane protein. Infect Immun 58 9 (1990) 3101-3108